title: Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass.
authors.affiliation: Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA.
authors.forename: Christopher F
authors.initials: CF
authors.lastname: Sulzer
authors.forename: G Burkhard
authors.initials: GB
authors.lastname: Mackensen
authors.forename: Hilary P
authors.initials: HP
authors.lastname: Grocott
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass; D002986:Clinical Trials as Topic; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D008171:Lung Diseases / Q000139:chemically induced / Q000473:pathology; D008775:Methylprednisolone / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control
chemical_list: D000893:Anti-Inflammatory Agents; D018696:Neuroprotective Agents; D008775:Methylprednisolone